VTVT VTVT
Company Profile ↓Company Overview
VTVT (VTVT) is a publicly traded company listed on with a market capitalization of $135.45M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.00.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue -100.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -100.00% |
Stock Price Performance
| 1 Year: | +135.95% |
| 6 Months: | -16.51% |
| 3 Months: | +8.14% |
| 1 Month: | +0.79% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Death Cross2d ago
- RSI (14)58.03 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 30.00K | 13.00K | 15.00K | 233.00K | 2.06M | 2.47M | 3.38M | 4.52M | 921.00K | 1.83M | 8.00K | 7.00K | 8.00K | - | 7.00K | 987.00K | 9.00K | 3.00M | 2.00M | 9.00K | 0 | 0 | 0 | 0 | 1.00M | 0 | 0 | - | 0 | 0 | 0 | 0 | 36.84M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.50M | 7.72M | 10.70M | 7.88M | 13.58M |
| Operating Income | -7.89M | -9.44M | -11.09M | -13.54M | -14.64M | -13.53M | -13.31M | -13.75M | -12.62M | -11.54M | -12.77M | -9.13M | -8.86M | -1.48M | -351.00K | -4.29M | -4.79M | -5.42M | -6.39M | -6.65M | -4.20M | -2.83M | -4.28M | -4.67M | -1.60M | -6.48M | -4.03M | -5.69M | -7.43M | -8.00M | -5.37M | -5.63M | -7.16M | -6.51M | - | -6.50M | -7.72M | -10.70M | -7.88M | 23.26M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.49M | -7.72M | -10.34M | -7.13M | 23.26M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | - | - | 5.00K | 1.00K | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.22M | -7.38M | -10.35M | -7.14M | 24.13M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | -10.41M | -4.10M | -3.17M | -3.85M | -4.46M | -3.99M | -4.05M | -4.22M | -3.96M | -3.65M | -4.31M | -2.95M | -3.07M | -796.00K | -1.09M | -2.15M | -2.88M | -3.61M | -4.40M | -4.72M | -3.37M | -1.53M | -4.24M | -608.00K | -1.09M | -7.01M | -3.15M | -4.26M | -4.50M | -5.62M | -6.65M | -4.87M | -5.18M | -4.78M | - | -5.09M | -6.05M | -8.70M | -7.14M | 24.13M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.77 | -0.92 | -1.08 | -0.58 | 1.65 |
| R&D Expense | 5.15M | 6.57M | - | 11.14M | 12.08M | 10.64M | - | 10.96M | 9.62M | 8.99M | - | 8.94M | 8.59M | 2.70M | - | 2.82M | 4.23M | 3.66M | - | 4.20M | 2.51M | 1.77M | 3.10M | 2.44M | 2.38M | 3.13M | 2.21M | 3.06M | 3.94M | 4.69M | 2.82M | 2.65M | 3.44M | 3.22M | - | 2.83M | 4.10M | 7.02M | - | 8.98M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 976.00K | 1.55M | 519.00K | 634.00K | 291.00K | 12.43M | 2.76M | 6.41M | 4.00M | 2.02M | 0 | 1.02M | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | 24.56M | 25.50M | 25.20M | 32.81M |
| Operating Income | -35.83M | -28.90M | -38.14M | -55.02M | -50.68M | -19.82M | -20.89M | -11.85M | -21.66M | -22.54M | -25.50M | -24.18M | -32.81M |
| EBITDA | - | - | - | - | - | - | - | - | - | -24.77M | -25.86M | -22.52M | -31.06M |
| Interest Expense | - | - | - | - | - | - | - | - | - | 15.00K | 13.00K | 0 | 6.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | -24.87M | -25.97M | -22.61M | -31.08M |
| Tax Provision | - | - | - | - | - | - | - | - | - | 200.00K | 0 | 100.00K | 0 |
| Net Income | -48.20M | -36.10M | -27.50M | -16.35M | -16.14M | -7.91M | -13.04M | -8.50M | -12.99M | -19.16M | -20.25M | -18.46M | -26.97M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | -10.40 | -9.71 | -3.20 | -3.20 |
| R&D Expense | 22.29M | 17.38M | 27.24M | 44.95M | 39.64M | 23.04M | 15.12M | 11.02M | 13.32M | 12.36M | 13.60M | 11.55M | 17.86M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 12.95M | 91.53M | 54.49M | 27.92M | 8.56M | 9.27M | 14.79M | - | 33.24M | 11.02M | 38.27M | 89.90M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | 27.09M | 10.66M | 38.11M | 89.89M |
| Cash & Equivalents | 2.12M | 1.09M | 1.38M | 88.00M | 51.51M | 11.76M | 1.68M | 1.78M | 5.75M | - | 12.13M | 9.45M | 36.75M | 88.93M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | 57.00K | 173.00K | 102.00K | 62.00K | - |
| Total Liabilities | - | - | 73.67M | 7.97M | 22.93M | 47.52M | 28.93M | 18.11M | 11.00M | - | 27.40M | 29.57M | 23.96M | 25.46M |
| Current Liabilities | - | - | 6.86M | 7.73M | 11.43M | 26.93M | 18.84M | 13.38M | 6.39M | - | 7.71M | 10.62M | 5.20M | 6.64M |
| Long Term Debt | - | - | 2.11M | - | 11.06M | - | 15.11M | 5.04M | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | 716.00K | 529.00K | 169.00K | 0 |
| Total Equity | -180.17M | -303.73M | -498.81M | -77.97M | -90.94M | -151.05M | -82.85M | -49.02M | -80.10M | - | -10.74M | -24.68M | 12.20M | 64.44M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | 2.04M | 2.08M | 2.61M | 3.94M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | -48.21M | -44.56M | -26.86M | -23.02M | -18.00M | - | -16.02M | -19.08M | -25.31M | -25.25M |
| Investing Cash Flow | - | - | - | -83.00K | -25.00K | 7.00K | 242.00K | 0 | - | -21.00K | 4.40M | 0 | 0 |
| Financing Cash Flow | - | - | - | 11.79M | 7.50M | 16.61M | 22.87M | 19.47M | - | 14.75M | 12.00M | 52.61M | 77.44M |
| Capital Expenditure | -181.00K | -33.00K | -104.00K | -87.00K | -57.00K | -5.00K | -70.00K | -0 | - | -21.00K | - | - | - |
| Free Cash Flow | - | - | - | -48.30M | -44.62M | -26.86M | -23.09M | -18.00M | - | -16.04M | -19.08M | -25.31M | -25.25M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | -1.29M | -2.68M | 27.30M | 52.19M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | -3,671.4% | -1,865.5% | -7,349.1% | -8,678.2% | -17,416.5% | -159.4% | -755.9% | -184.8% | -540.9% | -1,116.9% | - | -2,377.6% | - |
| Net Margin % | -4,938.8% | -2,330.6% | -5,298.3% | -2,579.2% | -5,547.8% | -63.6% | -471.9% | -132.5% | -324.3% | -949.7% | - | -1,815.3% | - |
| ROE % | 15.9% | 7.2% | 35.3% | 18.0% | 10.7% | 9.5% | 26.6% | 10.6% | - | 178.4% | 82.1% | -151.3% | -41.9% |
| ROCE % | - | -474.7% | -45.5% | -127.8% | -5,129.8% | 192.9% | 507.7% | -141.1% | - | -88.3% | -6,391.5% | -73.1% | -39.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for VTVT
vTv Therapeutics (VTVT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQM2Z0WTBYNy1HczRORHVtQThhbkdKMEdQM1c4M3lfYWI0X2VHUkhINnZORTV0OEhndHFIeDFqVW1hT1Z2NV84dUw2cmVKOWJPMkt5NUE3N0pDenVsUVhOa19MRG9LYngwdEZma1FYZUgyVUpDSEE3MXdGN253by0tMmNlMXBwZ1J5ekk2UG…
Precision Trading with Vtv Therapeutics Inc. (VTVT) Risk Zones - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOZldlYnNsX1lsM3p0cmhYYTlPSzctd0VvZm8yZC1FOEF2ZGEyZXV2andsSklOT1MxOTlDOGt5MmZwSjZFMlhTZ08yeXZxeEpGOGNPMlg5ZE5TVTZQalZ4TFBQX3VOMTlaOGVNR0JKc1dVQXM3S2hWQ0ZFQkE4a3AzckpCd0ZralhDSmZEU0…
vTv Therapeutics Inc. Revenue Breakdown – NASDAQ:VTVT - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1CQkgxb3p1c2tCOWctYWpnd25uY1ExUml0bWVfVmZUUXZFWGd1cUJUbW9YSUxZMks2TVlONURleUxnRUJhR3VGMWhmSUJzMHRWR05qYzc2TWZCWHAtVVdtbE9NZF85TXUzbTNpRUVGZHAxNmxhNlIw?oc=5" target="_blank">vTv The…
vTv Therapeutics Grants Employees Options With 4-Year Vesting - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOeWFXUHBVTUc5M0V3aFlhUmlON2ZUbVZoQnk3cnlSUlFSS2R1VGNIUl9vZW1GeG85V1B1b0w2YU05cFBXYUREQU42blV1ejhxTkhPQWxRUG9fakotaThVREI5ZjRDVHpURWhNek16eTJ3TUNERmtqRDE5NmltamdfbERUTm1aNlhWWHZMMH…
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOdkxRWkp6Nnh6bEhuU3k3VzVZenNGS1BpOTJYTERhbEU3dHhRcnZHTmptSDVCNFdBd3hRU3dBemctSTZLeVBmNVFRUGFiTS1VMko4NkVHU2lRTDlPY2lEd0pMSUVoTkRhdFVKOTlYS2JYcUozVmswWkg5c1JWMElNRi1SOTRYbjU1TlZteU…
vTv Therapeutics (NASDAQ:VTVT) Shares Pass Above Fifty Day Moving Average - Here's What Happened - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxORW9QX2xmQ3Rra1hJdnBRWS16cThSZndrVkFycFRTT0k4ckhhYWlPLU5uVkRaejlfU05xMllzeWR1eW1sNmh5ZGdVZXdNVFZuN2dmUm9uRmN4MFlxdVBNbDdWdl81OHhMZkpydWVLczZuV1gzOFFyVEZqSHRiSjgwX1pMTVVpR2F0dkQ2YX…
VTVT — Frequently Asked Questions
What is the current share price of VTVT?
As of 2026-08-05 17:25 PDT, VTVT trades at $34.39 on NASDAQ/NYSE. Its 52-week range is $14.00 to $42.72.
What is the market capitalisation of VTVT?
VTVT has a market capitalisation of $135.45M on NASDAQ/NYSE.
What is the P/E ratio of VTVT?
VTVT trades at a trailing price-to-earnings (P/E) ratio of -10.75. Its price-to-book (P/B) ratio is 2.10.
What is the return on equity (ROE) of VTVT?
VTVT has a return on equity (ROE) of -41.86%. Its return on capital employed (ROCE) is -39.41%.
Is VTVT a good stock to buy?
This page provides a data-driven analysis of VTVT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.